Normunity
PrivateLast Round
Series B
Jan 13, 2025
Est. Valuation
$500M
Total Funding Raised
$140M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Normunity operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in January 2025.
Normunity is a biotechnology company that develops precision immuno-oncology therapies designed to restore the immune system's natural ability to identify and eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Normunity Comparables
Compare Normunity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 84% | |
| Merck | 81% | |
| EvolveImmune | 80% |
For institutional investors. Book with your work email.
Normunity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Oct 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Normunity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Connecticut Innovations | Series B |
| Taiho Ventures | Series B, Series A |
| Osage University Partners | Series B, Series A |
| Canaan Partners | Series B, Series A |
| Pfizer Ventures | Series B |
| Sanofi Ventures | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM, reaching 2K.
- Jul 26, 2026
Monthly visitors grew 40% MoM, from 1K to 1.5K.
For institutional investors. Book with your work email.
Normunity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Normunity's valuation, stock price, and market status.
Is Normunity a public or private company?
Normunity is a private company.
What is the current stock price of Normunity?
Normunity is a private company, so its shares have no public market price. Caplight tracks Normunity's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Normunity worth (valuation)?
Normunity's valuation is estimated at $500.0M based on funding round data.
Can I buy Normunity stock?
Normunity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Normunity's last funding round?
Normunity's most recent funding round was Series B on January 13, 2025.
Who are the main investors in Normunity?
Key investors in Normunity include Enavate Sciences, Canaan Partners, Samsara BioCapital.
Will Normunity IPO soon?
No public IPO plans have been announced for Normunity.
How can I track Normunity secondary market activity?
Caplight tracks bids, offers, and trades in Normunity's shares on secondary markets.